NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Icosavax, Inc. (NASDAQ:ICVX)'s sale to AstraZeneca for $15.00 per share in cash plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones. If you are an Icosavax shareholder, click here to learn more about your rights and options.
RayzeBio, Inc. (NASDAQ:RYZB)'s sale to Bristol-Myers Squibb Company ...